Cellectar Biosciences, Inc. · NASDAQ:CLRB

Hexstone Capital LLC reported a 5.60% stake in Cellectar Biosciences, Inc. (Schedule 13G)

Event Jul 2, 2025 · Filed Aug 8, 2025

Hexstone Capital LLC reported a 5.60% stake in Cellectar Biosciences, Inc., 150,000 shares, as a passive investor on Jul 2, 2025. Filed Aug 8, 2025 (Schedule 13G).

Stake
5.60%
Shares
150,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Hexstone Capital LLC5.60%150,000
Brendan O'Neil5.60%150,000

Source

View original at SEC

Related